Zhongmou Therapeutics
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Novel Gene Therapy AGX-08 for Geographic Atrophy (NCT07602127) | Zhongmou Therapeutics | 2026-07-01 |
| Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection) (NCT07282457) | Zhongmou Therapeutics | 2026-06-25 |
| Natural History Study of Inherited Retinal Diseases (NCT07085533) | Zhongmou Therapeutics | 2025-07-20 |
| Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients (NCT06292650) | Zhongmou Therapeutics | 2024-02-25 |
| Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients (NCT06066008) | Zhongmou Therapeutics | 2022-09-25 |
Track Zhongmou Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.